This company has been acquired
Ocean Bio-Chem Future Growth
Future criteria checks 0/6
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Household Products earnings growth | 8.2% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Here's Why Ocean Bio-Chem (NASDAQ:OBCI) Can Manage Its Debt Responsibly
Jun 23Capital Investments At Ocean Bio-Chem (NASDAQ:OBCI) Point To A Promising Future
Apr 07Ocean Bio-Chem (NASDAQ:OBCI) Might Become A Compounding Machine
Dec 16Ocean Bio-Chem's (NASDAQ:OBCI) Dividend Will Be US$0.03
Nov 26Ocean Bio-Chem's (NASDAQ:OBCI) Shareholders Have More To Worry About Than Only Soft Earnings
Nov 22These 4 Measures Indicate That Ocean Bio-Chem (NASDAQ:OBCI) Is Using Debt Safely
Nov 03Ocean Bio-Chem (NASDAQ:OBCI) Will Pay A Dividend Of US$0.03
Sep 02With EPS Growth And More, Ocean Bio-Chem (NASDAQ:OBCI) Is Interesting
Aug 17Ocean Bio-Chem And Its Real Value
Aug 05Is Ocean Bio-Chem (NASDAQ:OBCI) A Risky Investment?
Jul 27Estimating The Intrinsic Value Of Ocean Bio-Chem, Inc. (NASDAQ:OBCI)
May 29Investors Should Be Encouraged By Ocean Bio-Chem's (NASDAQ:OBCI) Returns On Capital
May 17Ocean Bio-Chem (NASDAQ:OBCI) Seems To Use Debt Rather Sparingly
Mar 17Be Sure To Check Out Ocean Bio-Chem, Inc. (NASDAQ:OBCI) Before It Goes Ex-Dividend
Mar 05Why Ocean Bio-Chem, Inc. (NASDAQ:OBCI) Is A Dividend Rockstar
Feb 22Why We Like The Returns At Ocean Bio-Chem (NASDAQ:OBCI)
Feb 09Is Weakness In Ocean Bio-Chem, Inc. (NASDAQ:OBCI) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
Jan 27Do Ocean Bio-Chem's (NASDAQ:OBCI) Earnings Warrant Your Attention?
Jan 14This Insider Has Just Sold Shares In Ocean Bio-Chem, Inc. (NASDAQ:OBCI)
Jan 01Shareholders of Ocean Bio-Chem (NASDAQ:OBCI) Must Be Delighted With Their 610% Total Return
Dec 28Ocean Bio-Chem, Inc. (NASDAQ:OBCI) Insiders Have Been Selling
Dec 15Is Ocean Bio-Chem (NASDAQ:OBCI) Using Too Much Debt?
Dec 03Ocean Bio-Chem goes ex-dividend tomorrow
Dec 01Ocean Bio-Chem authorizes $3M share repurchase program
Nov 23A Quick Analysis On Ocean Bio-Chem's (NASDAQ:OBCI) CEO Salary
Nov 21Ocean Bio-Chem Has Maintained Momentum, But Not Enough For New Highs
Nov 19In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Ocean Bio-Chem has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
6/30/2022 | 63 | 5 | -7 | 0 | N/A |
3/31/2022 | 64 | 8 | -4 | 4 | N/A |
12/31/2021 | 64 | 8 | -2 | 6 | N/A |
9/30/2021 | 63 | 9 | 0 | 5 | N/A |
6/30/2021 | 61 | 10 | 4 | 7 | N/A |
3/31/2021 | 61 | 11 | 5 | 7 | N/A |
12/31/2020 | 56 | 10 | 4 | 6 | N/A |
9/30/2020 | 52 | 9 | 4 | 6 | N/A |
6/30/2020 | 46 | 6 | 4 | 5 | N/A |
3/31/2020 | 41 | 3 | 6 | 7 | N/A |
12/31/2019 | 42 | 3 | 5 | 6 | N/A |
9/30/2019 | 41 | 3 | 3 | 4 | N/A |
6/30/2019 | 42 | 3 | 1 | 2 | N/A |
3/31/2019 | 42 | 3 | -1 | 0 | N/A |
12/31/2018 | 42 | 3 | -1 | 1 | N/A |
9/30/2018 | 42 | 3 | -1 | 2 | N/A |
6/30/2018 | 40 | 3 | -2 | 2 | N/A |
3/31/2018 | 38 | 3 | -2 | 3 | N/A |
12/31/2017 | 38 | 3 | -2 | 3 | N/A |
9/30/2017 | 38 | 3 | -1 | 3 | N/A |
6/30/2017 | 39 | 3 | 0 | 3 | N/A |
3/31/2017 | 38 | 3 | 2 | 3 | N/A |
12/31/2016 | 36 | 2 | 3 | 3 | N/A |
9/30/2016 | 36 | 2 | 1 | 2 | N/A |
6/30/2016 | 35 | 0 | 0 | 0 | N/A |
3/31/2016 | 35 | 0 | N/A | 2 | N/A |
12/31/2015 | 34 | 0 | N/A | 1 | N/A |
9/30/2015 | 34 | 1 | N/A | 1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if OBCI's forecast earnings growth is above the savings rate (1.9%).
Earnings vs Market: Insufficient data to determine if OBCI's earnings are forecast to grow faster than the US market
High Growth Earnings: Insufficient data to determine if OBCI's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if OBCI's revenue is forecast to grow faster than the US market.
High Growth Revenue: Insufficient data to determine if OBCI's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if OBCI's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2022/08/09 13:20 |
End of Day Share Price | 2022/08/08 00:00 |
Earnings | 2022/06/30 |
Annual Earnings | 2021/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Ocean Bio-Chem, Inc. is covered by 0 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|